There were fewer cardiac events at 2 years for MI patients with LVEF 40% to 49% discharged on beta blockers and, separately, renin-angiotensin-system inhibitors in a propensity-matched cohort study.
New population-based data suggest that patients who don t receive care for NSTEMI within 24 hours have a substantially increased risk of mortality 3 years later.